A股重磅！科创成长层，要上新

Core Viewpoint - Wuhan Heyuan Biotechnology Co., Ltd. has officially launched its issuance work by disclosing its prospectus, issuance arrangements, and preliminary inquiry announcement on the Shanghai Stock Exchange, marking a significant step in the "1+6" reform of the Sci-Tech Innovation Board [1][3]. Group 1: Company Overview - Heyuan Biotechnology is the first company to initiate the issuance process among the newly registered enterprises in the Sci-Tech Growth Layer, following the resumption of the fifth set of standards for the Sci-Tech Innovation Board [5]. - The company has developed a globally pioneering "rice-derived hematopoiesis" technology, which has received support from the national "Major New Drug Creation" technology major project [6]. - Heyuan's self-developed innovative drug, recombinant human albumin injection (from rice), was approved for market release by the National Medical Products Administration in July, aiming to reduce China's long-term reliance on imported human serum albumin [6]. Group 2: Market Context - The issuance of Heyuan Biotechnology is a reflection of the implementation of the "1+6" reform on the Sci-Tech Innovation Board, enhancing the system's inclusiveness and adaptability for high-quality technology enterprises [6]. - The company is the first to adopt differentiated lock-up and allocation arrangements for offline issuance, with a minimum overall lock-up ratio of 40% and three tiers of differentiated lock-up levels for investors [6]. - The Shanghai Stock Exchange has revised its issuance and underwriting rules, allowing unprofitable companies to adopt agreed lock-up methods, encouraging professional institutions to play a larger role in new stock pricing [6][10]. Group 3: Industry Developments - Since the announcement of the "1+6" reform policy in June, the Sci-Tech Innovation Board has received IPO applications from 15 new companies, including four unprofitable enterprises [7]. - Currently, three unprofitable companies have received IPO registration approval, with two of them adhering to the fifth set of standards [8]. - The technical systems of the Shanghai Stock Exchange have completed full network testing, and preparations for the issuance of new registered enterprises in the Sci-Tech Growth Layer are underway [9].